AstraZeneca PLC Board Committee Changes (2581B)
2022年9月30日 - 06:30PM
RNSを含む英国規制内ニュース (英語)
TIDMAZN
RNS Number : 2581B
AstraZeneca PLC
30 September 2022
30 September 2022 10:30 BST
Remuneration Committee Chair Appointment
AstraZeneca PLC today announced the appointment of Sheri McCoy,
Non-Executive Director, as Chair of the Remuneration Committee.
Sheri has served as a member of the Remuneration Committee since
July 2018.
Sheri will succeed Michel Demaré who will step down as Chair of
the Remuneration Committee following his recent appointment as
Chair-designate of the Board. He will remain a member of the
Committee.
Sheri will also become a member of the Nomination and Governance
Committee.
These Remuneration Committee and Nomination and Governance
Committee changes are effective from 1 December 2022. As previously
announced, Michel Demaré will become Chair of the Board at the end
of the Company's Annual General Meeting in April 2023.
Notes
Biography and photograph:
https://www.astrazeneca.com/our-company/leadership.html#board
AstraZeneca
AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led
biopharmaceutical company that focuses on the discovery,
development, and commercialisation of prescription medicines in
Oncology, Rare Diseases, and BioPharmaceuticals, including
Cardiovascular, Renal & Metabolism, and Respiratory &
Immunology. Based in Cambridge, UK, AstraZeneca operates in over
100 countries and its innovative medicines are used by millions of
patients worldwide. Please visit astrazeneca.com and follow the
Company on Twitter @AstraZeneca .
Contacts
For details on how to contact the Investor Relations Team,
please click here . For Media contacts, click here .
Adrian Kemp
Company Secretary
AstraZeneca PLC
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
BOAPPURWBUPPPUB
(END) Dow Jones Newswires
September 30, 2022 05:30 ET (09:30 GMT)
Astrazeneca (LSE:AZN)
過去 株価チャート
から 2 2024 まで 3 2024
Astrazeneca (LSE:AZN)
過去 株価チャート
から 3 2023 まで 3 2024